dc.contributor.author | Bilici, Ahmet | |
dc.contributor.author | Ölmez, Ömer Fatih | |
dc.contributor.author | Sezer, Ahmet | |
dc.contributor.author | Öksüzoğlu, Berna | |
dc.contributor.author | Kaplan, Muhammet Ali | |
dc.contributor.author | Karadurmuş, Nuri | |
dc.contributor.author | Çubukçu, Erdem | |
dc.contributor.author | Şendur, Mehmet Ali Nahit | |
dc.contributor.author | Aksoy, Sercan | |
dc.contributor.author | Erdem, Dilek | |
dc.contributor.author | Başaran, Gül | |
dc.contributor.author | Çakar, Burcu | |
dc.contributor.author | Şeker, Mesut | |
dc.contributor.author | Arslan, Çağatay | |
dc.contributor.author | Sezgin Göksu, Sema | |
dc.contributor.author | Çiçin, İrfan | |
dc.contributor.author | Gümüş, Mahmut | |
dc.contributor.author | Selçukbiricik, Fatih | |
dc.contributor.author | Harputluoğlu, Hakan | |
dc.contributor.author | Helvacı, Kaan | |
dc.date.accessioned | 2022-11-07T09:12:18Z | |
dc.date.available | 2022-11-07T09:12:18Z | |
dc.date.issued | 2022 | en_US |
dc.identifier.citation | Bilici, A., Ölmez, Ö. F., Sezer, A., Öksüzoğlu, B., Kaplan, M. A., Karadurmuş, N. ... Helvacı, K. (2022). Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study). Journal of Clinical Oncology. | en_US |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/9933 | |
dc.description.abstract | ... | en_US |
dc.description.sponsorship | Roche Holding | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Lippincott Williams and Wilkins | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | HER2PATH Study | en_US |
dc.subject | Breast Cancer | en_US |
dc.subject | Analysis of Pathologic | en_US |
dc.title | Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study) | en_US |
dc.type | conferenceObject | en_US |
dc.relation.ispartof | Journal of Clinical Oncology | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | en_US |
dc.identifier.volume | 40 | en_US |
dc.identifier.issue | 16 | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.identifier.wos | 000863680302513 | en_US |